Ligand validation:7GRY

DMS: DIMETHYL SULFOXIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7GRY_DMS_A_401	100%	68%	0.046	0.988	0.75	0.51	-	-	0	0	100%	1
7GRY_DMS_B_402	99%	70%	0.053	0.992	0.72	0.44	-	-	0	0	100%	1
7GRY_DMS_B_401	99%	63%	0.055	0.99	0.65	0.76	-	-	0	0	100%	1
7GRY_DMS_B_403	86%	58%	0.089	0.956	0.65	0.97	-	-	4	0	100%	1
7GRY_DMS_A_404	83%	24%	0.11	0.97	0.73	2.33	-	1	2	0	100%	1
7GRY_DMS_A_405	72%	45%	0.118	0.942	0.92	1.19	-	-	0	0	100%	1
7GRY_DMS_A_402	71%	74%	0.117	0.936	0.81	0.22	-	-	0	0	100%	1
7GRY_DMS_A_403	63%	66%	0.114	0.91	0.47	0.82	-	-	0	0	100%	1
7GRY_DMS_B_404	33%	64%	0.181	0.86	0.71	0.67	-	-	0	0	100%	1
7GES_DMS_A_401	100%	86%	0.037	0.994	0.38	0.33	-	-	0	0	100%	1
5RFZ_DMS_A_401	100%	95%	0.04	0.993	0.26	0.14	-	-	0	0	100%	1
7AXM_DMS_A_503	100%	65%	0.041	0.994	0.62	0.73	-	-	0	0	100%	1
5REG_DMS_A_403	100%	97%	0.042	0.993	0.18	0.14	-	-	0	0	100%	1
5REU_DMS_A_401	100%	97%	0.043	0.994	0.26	0.08	-	-	0	0	100%	1
6TOV_DMS_A_102	100%	88%	0.028	0.998	0.33	0.35	-	-	0	0	100%	1
6TVE_DMS_P_604	100%	90%	0.031	0.997	0.47	0.15	-	-	0	0	100%	1
5RXA_DMS_A_903	100%	88%	0.032	0.994	0.18	0.48	-	-	0	0	100%	1
7QY0_DMS_A_610	100%	76%	0.032	0.997	0.67	0.3	-	-	0	0	100%	1
5RXR_DMS_A_902	100%	89%	0.037	0.995	0.16	0.47	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.